Wechselwirkungen · Flebogamma DIF (previously Flebogammadif)
Flebogamma DIF 50 mg/ml solution for infusion · Abschnitt 4.5 · PDF-Seite 9
HOS-117919 · Präparat HOS-094719
Immunoglobulin administration may impair for a period of at least 6 weeks and up to 3 months the efficacy of live attenuated virus vaccines such as measles, rubella, mumps and varicella. After administration of this medicinal product, an interval of 3 months should elapse before vaccination with live attenuated virus vaccines. In the case of measles, this impairment may persist for up to 1 year. Therefore, patients receiving measles vaccine should have their antibody status checked.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-11-06T02:00:00Z · SHA-256 aaf3d6ea05789cac267bf301b3a1cb88d5c48ea482f96614700055f27264d8af · Passage 15c0c02c244fe3ba988ffeb5f06639ffe9410333ae22bf8de2f3de18834cee76 · Zeichen 32–519 im Abschnitt